Toggle navigation
Home
Search
Services
Blog
Contact
About
Total Synthesis of Antitumor Agent Octalactin A
Pedersen, Michelle L.
University of Pennsylvania, Philadelphia, PA, United States
Search grants from Michelle Pedersen
Search grants from University of Pennsylvania
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Phase II Trial of Gemcitabine & Triapine in Refractory Metastatic Breast Cancer
Generating antibodies against N-Acyl homoserine lactones
Genetics of Human Lymphocyte Antigen CD8
X-Linked Nephrolithiasis - Molecular and Clinical Studies
Biomarkers for Occupational Solvent Exposure
Recently added grants:
High-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cells
Rapid evaluation of immunotherapy regimens in ex vivo human pancreatic tumor slice cultures.
Inflammation and the Treatment of Primary Pneumonic Plague
Functions of TBK1 in neutrophils during bacterial pneumonia
Telehealth to Improve Prevention of Suicide (TIPS) in EDs
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32CA072168-02
Application #
2545419
Study Section
Special Emphasis Panel (ZRG3-BNP (02))
Project Start
1997-10-01
Project End
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
University of Pennsylvania
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Related projects
NIH 1997
F32 CA
Total Synthesis of Antitumor Agent Octalactin A
Pedersen, Michelle L. / University of Pennsylvania
NIH 1996
F32 CA
Total Synthesis of Antitumor Agent Octalactin A
Pedersen, Michelle L. / University of Pennsylvania
Comments
Be the first to comment on Michelle Pedersen's grant